Identifying Cancer-Specific Proteins Using Next-Gen Protein Sequencing™
Case Study
“While mass spectrometry is a powerful tool for proteomics, it has limitations. We see Quantum-Si’s Platinum® technology as an approach that could enhance our ability to identify cancer-specific proteins, ultimately making our research more efficient.”
— Glenn Gregorio, PhD
Associate Director of Structural Biology and Protein Engineering
Sanavia Oncology
Explore this case study to see how Sanavia Oncology’s interest in Next-Gen Protein Sequencing™ (NGPS™) using the Quantum-Si’s Platinum® instrument stems from their need to better characterize novel cancer targets, and why they see it as a crucial tool in their target identification workflow.